Evidence map›Paper›PMID 33351785›Full record

ArticleJCI insight2021

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.

Rachel L Rutishauser, Christian Deo T Deguit, Joseph Hiatt, Franziska Blaeschke, Theodore L Roth, Lynn Wang, Kyle A Raymond, Carly E Starke, Joseph C Mudd, Wenxuan Chen and 16 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 78 citations in OpenAlex.

  1. Trial
  2. Persistent cytolytic CD8Cell reports. Medicine · 2026
    Article
  3. CD8Cell reports. Medicine · 2026
    Review
  4. Article
  5. Renaissance of antiviral CD8Nature reviews. Immunology · 2026
    Review
  6. NK-like and networked CD8bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. HIV controllers, lessons learnt from the lymphoid tissues.Current opinion in HIV and AIDS · 2026
    Review
  16. Article
  17. Article
  18. CD8Nature · 2026
    Article
  19. Review
  20. Targeting the pDC/IFN-I axis in HIV-1 immunotherapy.Current opinion in HIV and AIDS · 2026
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 4 institutions in 2 countries.

Rachel L RutishauserDepartment of Medicine, UCSF, San Francisco, California, USA.
Christian Deo T DeguitDepartment of Medicine, UCSF, San Francisco, California, USA.
Joseph HiattDepartment of Microbiology and Immunology.
Franziska BlaeschkeDepartment of Microbiology and Immunology.
Theodore L RothDepartment of Microbiology and Immunology.
Lynn WangDepartment of Medicine, UCSF, San Francisco, California, USA.
Kyle A RaymondVitalant Research Institute, San Francisco, California, USA.
Carly E StarkeBarrier Immunity Section, Laboratory of Viral Diseases and.
Joseph C MuddBarrier Immunity Section, Laboratory of Viral Diseases and.
Wenxuan ChenDepartment of Medicine, UCSF, San Francisco, California, USA.
Carolyn SmullinDepartment of Medicine, UCSF, San Francisco, California, USA.
Rodrigo Matus-NicodemosHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Rebecca HohDepartment of Medicine, UCSF, San Francisco, California, USA.
Melissa KroneDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.
Frederick M HechtDepartment of Medicine, UCSF, San Francisco, California, USA.
Christopher D PilcherDepartment of Medicine, UCSF, San Francisco, California, USA.
Jeffrey N MartinDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, California, USA.
Richard A KoupImmunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases , NIH, Bethesda, Maryland, USA.
Daniel C DouekHuman Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Jason M BrenchleyBarrier Immunity Section, Laboratory of Viral Diseases and.
Rafick-Pierre SékalyDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Satish K PillaiVitalant Research Institute, San Francisco, California, USA.
Alexander MarsonDepartment of Medicine, UCSF, San Francisco, California, USA.
Steven G DeeksDepartment of Medicine, UCSF, San Francisco, California, USA.
Joseph M McCuneDepartment of Medicine, UCSF, San Francisco, California, USA.
Peter W HuntDepartment of Medicine, UCSF, San Francisco, California, USA.
University of California, San Francisco · USNational Institute of Allergy and Infectious Diseases · USNational Student Clearinghouse Research Center · USCase Western Reserve University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MALLORY O JOHNSON · 1988 to 2026
$93.6M
X-ray Screening and Rapid Structure DeterminationP50GM082250 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2007 to 2018
$48.8M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Testing of Blood Samples for Immune Response and Vaccine ResearchZIAAI005073 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KOUP, RICHARD A · 2009 to 2025
$23.4M
Host Genomic Factors in Infectious Disease Susceptibility ZIAAI005066 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2025
$17.9M
The Genome Analysis CoreZICAI005133 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2019 to 2025
$16.9M
X-ray Screening and Rapid Structure DeterminationP50AI150476 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2019 to 2021
$14.4M
T Cell Immune Responses To HIV And Other PathogensZIAAI005033 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2025
$11.4M
The HIV ReservoirZIAAI005034 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2025
$7.5M
NCATS NIH HHS UL1 TR001872NIAID NIH HHS K23 AI134327NIAID NIH HHS K24 AI069994NIAID NIH HHS K24 AI145806NIAID NIH HHS P30 AI027763NIAID NIH HHS P50 AI150476NIAID NIH HHS R01 AI110271NIAID NIH HHS R01 AI116368NIAID NIH HHS R01 AI150449NIAID NIH HHS R24 AI067039NIAID NIH HHS T32 AI060530NICHD NIH HHS R01 HD074511NIGMS NIH HHS P50 GM082250NIGMS NIH HHS R01 GM117901NIGMS NIH HHS T32 GM007618NIH HHS P51 OD011104
6 · The paper itself

Abstract

Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus-specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell-based therapeutic strategies for HIV.

Indexed as

AdultAgedAnimalsCD8-Positive T-LymphocytesFemaleGene Knockout TechniquesHIV-1HIV AntigensHIV InfectionsHumansImmunologic MemoryMacaca mulattaMaleMiddle AgedSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusHIV AntigensT Cell Transcription Factor 1TCF7 protein, humanAdaptive immunityAIDS/HIVImmunologyT cells

Identifiers

PMID33351785
PMCPMC7934879
OpenAlexW3117041241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.